Trial intelligence / Profile preview

Sodium valproate versus placebo in paediatric and adult patients with Wolfram syndrome

ISRCTN10176118Phase 2Completed

Sponsor
University of Birmingham
Start
Jan 2019
Modality
Small Molecules
01

Overview

Phase 2, randomised, double-blind trial in Wolfram syndrome comparing Sodium valproate with Placebo (2 arms). Primary endpoint: Visual acuity at Day 1080. Started Jan 2019; status: completed.

02

Drugs

valproic acid
03

Conditions

Wolfram syndrome

Beyond the preview

Go deeper on ISRCTN10176118.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN10176118.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call